Legal Implications of Eli Lilly and Company v. The Government of Canada – for Pharmaceutical-Related Intellectual Property Investment
碩士 === 東吳大學 === 法律學系 === 107 === In 2013, Eli Lilly submitted Notice of Arbitration against the Government of Canada in accordance with NAFTA under ISDS. Eli Lilly claimed that the patent invalidation decisions made by Canada courts based on the judge-made law of “Utility Promise Doctrine” violated...
Main Authors: | CHENG, KO-HAN, 鄭可涵 |
---|---|
Other Authors: | WU, PI-JAN |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/55vdbf |
Similar Items
-
Patent Judicial Expropriation Under International Investment Law — with the Focus on Eli Lilly v. Canada
by: Chang, Heng-Jui, et al.
Published: (2018) -
Were Eli Lilly unaware of this study?
by: Aasa Reidak
Published: (2006-09-01) -
AN INTERNSHIP AS A SCIENTIFIC COMMUNICATIONS ASSOCIATE AT ELI LILLY AND COMPANY
by: Crowder, Julie K.
Published: (2004) -
Eli Lilly and Beyond The Role of International Intellectual Property Treaties in Establishing Legitimate Expectations in Investor-State Dispute Settlement
Published: (2018) -
Challenges encountered diffusing tacit knowledge at Eli Lilly SA
by: P. Gichuru, et al.
Published: (2004-01-01)